# 摘要

| Ref | Title | Summary |
| --- | --- | --- |
| [^1] | [Supervised machine learning for microbiomics: bridging the gap between current and best practices](https://arxiv.org/abs/2402.17621) | 该研究通过分析大量期刊文章，总结了监督机器学习在微生物组学中的现有实践，探讨了实验设计方法的优缺点，并提出了如何避免常见实验设计缺陷的指导。 |

# 详细

[^1]: 用于微生物组学的监督机器学习：弥合当前和最佳实践之间的差距

    Supervised machine learning for microbiomics: bridging the gap between current and best practices

    [https://arxiv.org/abs/2402.17621](https://arxiv.org/abs/2402.17621)

    该研究通过分析大量期刊文章，总结了监督机器学习在微生物组学中的现有实践，探讨了实验设计方法的优缺点，并提出了如何避免常见实验设计缺陷的指导。

    

    机器学习（ML）将加速临床微生物组学创新，如疾病诊断和预后。这将需要高质量、可重现、可解释的工作流程，其预测能力达到或超过监管机构对临床工具设定的高门槛。我们通过深入分析2021-2022年发表的100篇同行评议的期刊文章，捕捉了当前将监督ML应用于微生物组学数据的实践的一个快照。我们采用数据驱动方法，引导讨论各种实验设计方法的优点，包括关键考虑因素，如如何减轻小数据集大小的影响同时避免数据泄漏。我们进一步提供关于如何避免可能损害模型性能、可信度和可重复性的常见实验设计缺陷的指南。讨论附有一个互动在线教程。

    arXiv:2402.17621v1 Announce Type: cross  Abstract: Machine learning (ML) is set to accelerate innovations in clinical microbiomics, such as in disease diagnostics and prognostics. This will require high-quality, reproducible, interpretable workflows whose predictive capabilities meet or exceed the high thresholds set for clinical tools by regulatory agencies. Here, we capture a snapshot of current practices in the application of supervised ML to microbiomics data, through an in-depth analysis of 100 peer-reviewed journal articles published in 2021-2022. We apply a data-driven approach to steer discussion of the merits of varied approaches to experimental design, including key considerations such as how to mitigate the effects of small dataset size while avoiding data leakage. We further provide guidance on how to avoid common experimental design pitfalls that can hurt model performance, trustworthiness, and reproducibility. Discussion is accompanied by an interactive online tutorial th
    

